- Release Date: 11/03/24 08:55
- Summary: New case of SCENESSE efficacy in vitiligo presented at AAD
- Price Sensitive: Yes
- Download Document 362.39KB
- Forums
- ASX - By Stock
- CUV
- Ann: New case of SCENESSE efficacy in vitiligo presented at AAD
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
2.79%
!
$11.51

Ann: New case of SCENESSE efficacy in vitiligo presented at AAD
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$11.51 |
Change
-0.330(2.79%) |
Mkt cap ! $580.9M |
Open | High | Low | Value | Volume |
$11.84 | $11.97 | $11.50 | $1.121M | 96.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 872 | $11.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.51 | 149 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 110 | 11.510 |
7 | 696 | 11.500 |
3 | 174 | 11.490 |
6 | 368 | 11.480 |
5 | 561 | 11.470 |
Price($) | Vol. | No. |
---|---|---|
11.530 | 25 | 4 |
11.540 | 174 | 3 |
11.550 | 244 | 7 |
11.560 | 384 | 7 |
11.570 | 92 | 3 |
Last trade - 13.35pm 18/09/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |